![Journal of the American Society of Nephrology (JASN) podcast](/assets/images/square.png)
sGC Activator Avenciguat for CKD
0:00
21:55
Dr. Hiddo J.L. Heerspink discusses the findings from his study, "Effect of Avenciguat on Albuminuria in Patients with CKD: Two Randomized Placebo-Controlled Trials" with JASN Editor-in-Chief Rajnish Mehrotra.
Otros episodios de "Journal of the American Society of Nephrology (JASN)"
No te pierdas ningún episodio de “Journal of the American Society of Nephrology (JASN)”. Síguelo en la aplicación gratuita de GetPodcast.